The dense tropical forest and reddish-brown hills of Lote, located on India’s west coast, give way to a modest rise where a industrial facility stands under the open sky.
The factory is largely newly built, but its machinery is far from new: it comes from the former Miteni plant in Vicenza, Italy. Miteni closed down in 2018 after among the most severe ecological controversies in the nation’s modern record: after years of manufacturing persistent PFAS compounds, the firm’s leadership was prosecuted for polluting water resources in an region home to 350,000 people. In June, previous company leaders were convicted at the local tribunal of environmental damage and other charges and sentenced to jail, with appeals anticipated.
Understanding PFAS: Toxicity Levels and Exposure Routes
Nevertheless, all of the company’s equipment, its intellectual property and processes – all required components to produce Pfas – is now located at Lote Parshuram MIDC, a large industrial zone thousands of miles distant, sandwiched among local communities and groves of trees. And the plant has just started to produce forever chemicals again.
An Environmental Burden
Previously recognized for its specialism in creating methods for specialty compounds, Miteni is now notorious for the toxic legacy it bequeathed. In 2011, researchers found exceptionally elevated levels of Pfas in the plant’s wastewater. Hundreds of thousands of inhabitants had been exposed through potable water.
The most impacted were Miteni’s own workers. Ilario Ermetti, 69, who worked for decades in its specialty chemicals division, showed among the top levels of PFAS ever recorded in blood samples. “After the facts emerged, I reviewed a list of medical conditions associated with Pfas, and found out I had them all,” says Ermetti.
Elevated concentrations of PFAS in the blood are associated with increased risk of cancer, cardiovascular diseases, liver and kidney damage, reproductive disorders and additional ailments. Ermetti is presently recuperating from a recent surgical operation.
Community Concerns
Michela Piccoli, 51, a nurse and activist with Mamme No Pfas, started organizing after learning her offspring’s blood tests indicated elevated amounts of forever chemicals. When she learned that Miteni’s proprietary information and machinery were being transferred to India, she was stunned.
“Being parents, as females, our concern has grown,” she said. “Because our children are the children of all.”
Business Shift
After Miteni went bankrupt, its assets were bought in 2019 by Viva Lifesciences, a subsidiary of the domestic chemical corporation Laxmi Organic Industries – the only bidder in the public auction. By the start of 2023, all the equipment was travelling on freight ships heading to Mumbai. Meanwhile, Laxmi was boasting of its new acquisition to investors. Transcripts of investor gatherings show that Laxmi’s executives downplayed environmental concerns, with its chairman, Harshvardhan Goenka, declaring that Miteni was “doing everything legally in compliance with EU regulations”.
Goenka is a member on the directorate of Laxmi Organic Italy, a entity established in 2021. Another is Antonio Nardone, the last chief executive of Miteni, who was found guilty of environmental pollution and financial misreporting at the recent court case and given six years and four months in jail. Per a ex-supervisor requesting confidentiality, Nardone was traveling for work to India months before the firm’s collapse.
While Laxmi bought Miteni’s assets in June 2019, the environmental assessment report for the construction of the factory in Lote reveals that in March 2018 the company was already intending to start producing fluorochemicals matching Miteni’s offerings. Laxmi Organic Industries did not respond to requests for comment.
Strategic Expansion
By 2021, Laxmi’s plan clearly outlined the goal to “capture [the] market share of Miteni” and become a leader in the manufacturing of PFAS and fluorochemicals. Logistics data show that, to secure validation on the standard of the compounds, in 2024 Laxmi began distributing samples to companies with past business relationships with Miteni, including BASF, Chemours, DuPont and FMC.
From the beginning of 2025, Laxmi’s site in Lote Parshuram has been completely active, producing chemicals that will be utilized for pesticides, pharmaceuticals, dyes, beauty products and additional goods.
Environmental Oversight
Investigations have shown that levels of persistent pollutants in the environment are alarmingly high, particularly around manufacturing facilities. But even though international attention is growing, in India the matter is not yet a policy priority.
“Examining the rules, [Pfas] is not present in such guidelines. It’s unacknowledged by the Indian government as of today,” said Rajneesh Gautam, an environmental chemist at the academic institution. “Autonomous study teams across India have performed research in different states. But this work are limited in scope, and there are still only a handful.”
Regional Consequences
Parineeta Dandekar, head of the South Asia Network on Dams, Rivers, and People, says the Lote Parshuram manufacturing zone “has a dismal environmental track record”. After it was established in 1986, “the income source of fishing populations in this region completely collapsed,” she said.
The industrial area is dependent on a centralised wastewater treatment plant that has been at the forefront of complaints.
“Nearby communities have consistently reported that it’s not working properly,” said Dandekar. “When there is no electricity, a common occurrence in the countryside, the plant cannot function and factories discharge polluted water directly into the waterways.” Environmental authorities have issued multiple notices to the plant in the past few years.
Global Implications
In the EU, the regulatory agency is reviewing a plan to ban the manufacture, importation and use of more than 10,000 persistent compounds. This scrutiny may be driving the industry to the global south, per Claudia Marcolungo, a professor of environmental law at the academic institution. “I believe that this issue should be investigated, because the reality that Miteni’s production, intellectual assets and equipment have been relocated to a country like India should lead us to reflect, at the very least, on the power that these multinationals have to relocate in countries where there is clearly a lowering of standards in terms of ecological safeguards.”
Ongoing Risks
Miteni has shut down, but the firm’s harmful impact lives on – at the contaminated site in Vicenza, and in Lote. The medical effects associated with PFAS manufacturing are likely to affect communities that are already struggling with an unsafe environment for generations.
“The area has seen enough environmental destruction already,” says Dandekar. “Should additional hazardous firms move in, it’s perpetually concerning.”